Price $46.12 |
Market Cap
59.57B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
100.2
|
P/B
3.38
|
P/S
4.74
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
107.8
|
Op. Cash Flow
1.2M
|
FCF
0.3
|
|
Op. Margin
9.80%
|
Net Margin
4.80%
|
ROE
3.50%
|
ROI
4.50%
|
|
ROA
1.90%
|
EPS Growth
-46.00%
|
Current Ratio
1.5
|
Debt/Equity
53.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| RVL Pharmaceuticals PLC (RVLP) | $1.54 | - | - | 159.6M | Strong Buy |
| Star Equity Holdings Inc (STRR) | $1.01 | - | - | 15.8M | Strong Buy |
| HTG Molecular Diagnostics Inc (HTGM) | $0.32 | - | - | 5.3M | Strong Buy |
| Helius Medical Technologies In (HSDT) | $0.31 | - | - | 7.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.77 | - | - | 105.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
